Cepheid to establish plant for Xpert MTB/ RIF tests in India
US-based leading molecular diagnostics company, Cepheid Inc. (a wholly owned subsidiary of Danaher) unveiled its newest configuration in the GeneXpert family of systems, the GeneXpert Edge, in India recently. The company also announced its ‘Make in India’ initiative by announcing plans to establish their manufacturing footprint in the country for Xpert MTB/ RIF test cartridges which run on the GeneXpert System. More than 1,200 Cepheid’s GeneXpert Systems have been installed in the last 2 years at various Revised National Tuberculosis Control Program (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD). The GeneXpert Edge is expected to be available in India later this year. The GeneXpert Edge is a portable, easy-to-use system, developed specifically for nearpatient testing, to help support a one visit test-and-treat approach. With almost 17,000 systems in 182 countries, the GeneXpert System is the world’s most popular molecular diagnostics system. Its modular configuration makes it the most scalable platform available, delivering the ability to process from one to eighty tests simultaneously — enabling accurate, fast, and cost-effective test results in both lower volume pointof-care settings and higher volume reference laboratories.